SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia shares are under pressure as traders react to the boards investigation into Jensen Huangs admitted affair with a businesswoman reported to have suspected ties to Chinese intelligence, raising concerns about governance, possible information leaks, and Huangs future as CEO. The community is divided between seeing the probe and leadership uncertainty as a serious overhang and treating the controversy as unrelated to Nvidias AI-chip business and a buying opportunity.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is under heavy selling pressure ahead of its Q3 earnings report, with traders speculating about a possible leak while others see the decline as pre-report positioning; a leak is unconfirmed. Bulls point to growth and potential upbeat guidance, while bears worry that the Eli Lilly obesity-drug deal could pressure margins and profitability.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics quarterly revenue beat and higher full-year outlook, driven by BRIUMVI growth, are the main focus; shares saw a sharp post-results dip and recovery, prompting debate over a sell the news reaction versus short-driven volatility. Traders are also watching for Phase 3 results on subcutaneous BRIUMVI as a next potential catalyst.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWMs sharp rally is drawing attention as small caps outperform, with traders describing a possible low-volume short squeeze and rotation into the Russell 2000. Bulls are chasing calls and citing hopes for easing inflation, while skeptics question the moves strength given reported weak flows and limited volume.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors pending FDA decision on deramiocel for Duchenne muscular dystrophy, focused on the amended upper-limb-function evidence from HOPE-3, is driving attention ahead of the Nov. 22 PDUFA date. Bulls cite the trial data and a letter urging approval from 28 investigators, while skeptics point to FDA scrutiny and the earlier negative advisory-panel vote on the cardiac indication; short-squeeze speculation adds to the debate.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs rally is drawing attention after Oppenheimer upgraded the stock, while Google Clouds use of EPYC processors in its AI infrastructure added a company-specific catalyst. Traders also point to money rotating from Nvidia amid a CEO-related investigation, though some see the move as sentiment-driven and question AMDs valuation.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels SITC findings on immune activation and viral clearance, alongside its positive Phase 3 prostate-cancer results, are drawing attention as the company prepares a BLA for CAN-2409. Bulls see the data as supportive of the regulatory package, while skeptics question filing and manufacturing execution and warn of a possible sell-the-news reaction.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

A quarterly earnings shortfall and reduced full-year revenue guidance, tied largely to federal Dedrone drone deployments being delayed, have driven a sharp selloff. Traders debate whether the decline overreacts to a timing issue or reflects high valuation and weaker near-term growth, with some buying the dip and others expecting further downside.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk shares are rallying sharply ahead of its Q3 earnings report, with traders speculating about short covering and an earnings leak, though neither explanation is confirmed. The move has fueled hopes for a turnaround, while many investors worry that weak results or guidance could erase the gains.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Agility Robotics Inc.

Agility Robotics Inc. - Ordinary Shares - Class A

Post-merger selling in Agility Robotics is drawing attention, with traders pointing to typical de-SPAC volatility and questioning the companys steep losses, limited revenue, and path to commercial scale. Some remain bullish on humanoid robotics and the companys reported orders, but the discussion is dominated by skepticism about valuation and near-term execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ceva (CEVA) Lags Q3 Earnings and Revenue Estimates

Ceva (CEVA) delivered earnings and revenue surprises of -27.78% and -10.67%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

D-Wave Quantum Inc. (QBTS) Investors: December 15, 2026, Deadline in Securities Fraud Class Action Lawsuit - Kessler Topaz Meltzer & Check, LLP

D-Wave Quantum Inc. (QBTS) Investors: December 15, 2026, Deadline in Securities Fraud Class Action Lawsuit - Kessler Topaz Meltzer & Check, LLP D-Wave Quantum Inc. (QBTS) Investors: December 15, 2026, Deadline in Securities Fraud Class Action Lawsuit - Kessler Topaz Meltzer & Check, LLPPR...

Why Is D-Wave Quantum Stock Surging on Friday?

D-Wave Quantum stock jumped about 14% Friday in a broad quantum computing rally after peer IonQ topped third-quarter revenue estimates and raised its 2026 sales outlook, with D-Wave set to report its own results Tuesday.read more...

Pomerantz Law Firm Announces the Filing of a Class Action Against D-Wave Quantum Inc. and Certain Officers - QBTS

Pomerantz Law Firm Announces the Filing of a Class Action Against D-Wave Quantum Inc. and Certain Officers - QBTS Pomerantz Law Firm Announces the Filing of a Class Action Against D-Wave Quantum Inc. and Certain Officers - QBTSPR NewswireNEW YORK, Nov. 5, 2026 NEW YORK, Nov. 5, 2026 /PRNewswire...

D-Wave Quantum Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QBTS

D-Wave Quantum Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QBTS D-Wave Quantum Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QBTSPR NewswireNEW YORK, Nov. 5, 2026 NEW YORK, Nov. 5, 2026 /PRNewswire...

QBTS Investors Have Opportunity to Lead D-Wave Quantum Inc. Securities Fraud Lawsuit with SBS Law

QBTS Investors Have Opportunity to Lead D-Wave Quantum Inc. Securities Fraud Lawsuit with SBS Law QBTS Investors Have Opportunity to Lead D-Wave Quantum Inc. Securities Fraud Lawsuit with SBS LawPR NewswireLOS ANGELES, Nov. 5, 2026 LOS ANGELES, Nov. 5, 2026 /PRNewswire/ -- Schall, Brown & Schwartz...

QBTS Investor Alert: D-Wave Quantum Inc. Securities Class Action Notice - Contact SueWallSt

QBTS Investor Alert: D-Wave Quantum Inc. Securities Class Action Notice - Contact SueWallSt QBTS Investor Alert: D-Wave Quantum Inc. Securities Class Action Notice - Contact SueWallStPR NewswireNEW YORK, Nov. 5, 2026 Market Impact: QBTS ended August 2026 at $17.51 after a flat quarterly revenue...

Inseego (INSG) Reports Q3 Loss, Tops Revenue Estimates

Inseego (INSG) delivered earnings and revenue surprises of +20.59% and +8.35%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

IonQ Q3 2026 Earnings Tomorrow: Time to Buy Stock, Wait or Sell?

IonQ faces a pivotal Q3 earnings report as revenue growth and quantum advances clash with profitability concerns and falling estimates.

QBTS Deadline Alert: Levi & Korsinsky Reminds D-Wave Quantum Inc. (QBTS) Investors of Securities Class Action Deadline on December 15, 2026

QBTS Deadline Alert: Levi & Korsinsky Reminds D-Wave Quantum Inc. (QBTS) Investors of Securities Class Action Deadline on December 15, 2026 QBTS Deadline Alert: Levi & Korsinsky Reminds D-Wave Quantum Inc. (QBTS) Investors of Securities Class Action Deadline on December 15, 2026PR NewswireNEW YORK...

• Reported GAAP EPS of -$0.13 up 76.36% YoY
• Reported revenue of $3.08M down -0.61% YoY

D-Wave Quantum Inc. experienced margin compression, a 93% increase in GAAP operating expenses, and a 33% decline in cash and marketable investment securities compared to the prior year period.

D-Wave Quantum Inc. achieved 1,120% growth in first-half bookings, a 668% increase in remaining performance obligations, and received industry recognition as a Leader in the 2026 IDC MarketScape assessment.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. The firm offers annealing and gate-model quantum computing technologies. It provides professional services that assist customers in identifying and implementing quantum computing applications and selling quantum computer systems to customers. The company was founded by Eric Ladizinsky in 1999 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

QBTS, RGTI, QNT Stocks Rally After $100M Quantum Deals: US Government Takes Stakes In All Three

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>Each company has finalized a $100 million funding agreement with the U.S. Department of Commerce under the CHIPS and Science Act.</li><li>The government will receive a minority, non-controlling equity stake in each company in exchange for the funding.</li><li>The funding aims to address some of quantum computing’s biggest challenges, including scaling, reliability, manufacturing and supply-chain development.</li></ul>Shares of D-Wave Quantum (QBTS), Rigetti Computing (RGTI) and Quantinuum (QNT) rallied in early morning trade on&nbsp;Tuesday&nbsp;despite weakness in the broader market after&nbsp;the U.S. government finalized putting $100 million each behind the companies in a push to develop quantum computing.The government’s&nbsp;Department&nbsp;of Commerce will receive a minority, non-controlling equity stake in each company in exchange for the funding.&nbsp;<a href="https://stocktwits.com/symbol/QBTS">QBTS stock</a> rose over 4% in pre-market trade, while&nbsp;<a href="https://stocktwits.com/symbol/RGTI">RGTI stock</a> rallied as much as 7%.&nbsp;<a href="https://stocktwits.com/symbol/QNT">QNT shares</a> gained around 2.6%, still outperforming the broader market. The&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY) edged 0.26% lower ahead of&nbsp;the&nbsp;market’s opening, while the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF</a> (DIA) slipped 0.75% and the Nasdaq-100 tracking&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ) traded flat.&nbsp;RGTI and QBTS stocks&nbsp;were&nbsp;among the top trending tickers on Stocktwits at the time of writing. However, retail sentiment around them remained in ‘bearish’ territory over the past day.<h2 class="st-heading-2">Government Targets Quantum's Biggest Challenge</h2>Quantum computers are expected eventually tackle problems that are difficult or impossible for conventional computers, with potential applications in areas including drug discovery, materials science, cryptography, optimization and artificial intelligence.However, the technology remains difficult and expensive to scale. The companies are using different approaches to solve that problem, and all three government agreements focus heavily on moving quantum computing toward larger and more practical systems.<h2 class="st-heading-2">Where Does The $100M Go?</h2>Rigetti is using its $100 million award to address three hardware challenges. This includes shrinking the electronics used to read quantum chips, dramatically expanding the capacity of the extremely cold environments quantum computers require, and developing chips that allow more quantum bits, or qubits, to communicate with one another.D-Wave will use up to $100 million to develop both its quantum annealing and gate-model systems. Its targets include a 100,000-qubit annealing system and a 10,000-qubit gate-model system designed to deliver 100 logical qubits.Quantinuum, meanwhile, will use its $100 million award to scale its trapped-ion quantum technology, another approach to building quantum computers. The company plans to work with GlobalFoundries (GFS) to manufacture next-generation ion traps and electronics using 300mm wafers, while Monarch Quantum will help develop lasers and optical components.<a href="https://stocktwits.com/symbol/GFS">GFS stock</a> gained over 1% in pre-market trade, with retail sentiment on Stocktwits trending in ‘bearish’ territory over the past day.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/intc-stock-jumps-intel-asml-high-na-euv-tsmc-samsung/cZt3vOqRJUg">Samsung, TSMC Commit To ASML's Next-Gen Chip Machines, But Intel Got There First</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

3D illustration of a working quantum computer. Quantum computing concept (Photo by adventtr via Getty Images).

The U.S. government is committing a combined $300 million to D-Wave Quantum, Rigetti Computing and Quantinuum.

Quantinuum Inc.

Defiance Quantum ETF

Rigetti Computing Inc

Yes, still bullish

No, losing confidence

Waiting to see earnings first

Never was bullish

Quantum computing stocks - like $IONQ, $RGTI, and $QBTS - were very popular in 2025, but the sector remains pre-profit and highly speculative. Are you still bullish on quantum?

Stocktwits

IonQ Inc

 - were very popular in 2025, but the sector remains pre-profit and highly speculative. Are you still bullish on quantum?

Current Price	$11.71
Prev Close	$10.68
Open	$10.79
Dividend Yield	0.00%
50-Day Moving Average	$14.58
Beta	2.79
Avg. Volume	14.61M
PE Ratio	-15.07

52-Week High	$32.39
52-Week Low	$8.48
Market Capitalization	$4.05B
EPS (Annual)	-$1.11
Price to Book	3.67
Revenue Per Employee	$63,368.56

Feed

News

Sentiment

Earnings

Fundamentals

Info

QBTS Fundamentals